Design and Synthesis of the First-in-Class MC4R Antagonist, PF-07258669 with [4,5]-Spirocyclic Core (Synfacts, 2023)
Keywords: melanocortin-4-receptor antagonist; loss of appetite; clinical candidate; spirocycles; SBDD